Metoprine
Term · Oncology and biomedicine · MLC-T-ONC-015143
A diaminopyrimidine folate antagonist with potential antineoplastic activity. Metoprine inhibits dihydrofolate reductase, resulting in decreased cellular folate metabolism and cell growth; it also inhibits histamine-N-methyltransferase, resulting in decreased histamine catabolism. Lipid-soluble metoprine is capable of crossing the blood-brain barrier.
| Identifier | MLC-T-ONC-015143 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | DDMP |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015143",
"term": "Metoprine",
"field": "Oncology and biomedicine",
"definition": "A diaminopyrimidine folate antagonist with potential antineoplastic activity. Metoprine inhibits dihydrofolate reductase, resulting in decreased cellular folate metabolism and cell growth; it also inhibits histamine-N-methyltransferase, resulting in decreased histamine catabolism. Lipid-soluble metoprine is capable of crossing the blood-brain barrier.",
"abbreviation": "DDMP",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/metoprine/"
}
Record 10,963 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.